Cas:23735-43-5 [(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl 4-methylbenzenesulfonate manufacturer & supplier

Chemical Name:[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl 4-methylbenzenesulfonate

CAS.NO:23735-43-5

Synonyms:2,3-Isopropylidene-sn-glycerol 1-tosylate;1,3-Dioxolane-4-methanol, 2,2-dimethyl-, 4-methylbenzenesulfonate;(2,2-Dimethyl-1,3-dioxolan-4-yl)methyl 4-methylbenzenesulfonate;(S)-(+)-2,2-Dimethyl-1,3-dioxolane-4-ylmethyl p-Toluenesulfonate;(S)-(+)-2,2-DiMethyl-1,3-dioxolan-4-ylMethyl p-Toluenesulfonate;MFCD00063234;(S)-(+)-2,2-Dimethyl-4-(hydroxymethyl)-1,3-dioxolane-p-toluenesulfonate;L-(+)-1,2-Isopropylideneglycerol 3-(p-Toluenesulfonate);L-glycero-2,3-dihydroxy-2,3-O-isopropylidenepropyl p-toluenesulfonate

Molecular Formula:C₁₃H₁₈O₅S

Molecular Weight:286.344

HS Code:

Physical and Chemical Properties:

Melting point:29-31ºC

Boiling point:400.1±25.0 °C at 760 mmHg

Density:1.2±0.1 g/cm3

Index of Refraction:1.507

PSA:70.21000

Exact Mass:286.087494

LogP:1.58

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like 2,3-Isopropylidene-sn-glycerol 1-tosylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,L-glycero-2,3-dihydroxy-2,3-O-isopropylidenepropyl p-toluenesulfonate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(2,2-Dimethyl-1,3-dioxolan-4-yl)methyl 4-methylbenzenesulfonate Use and application,MFCD00063234 technical grade,usp/ep/jp grade.

Related News: As a result, the team identified and prioritized studies that would provide the necessary product and process understanding needed to develop a control strategy, ensure the reproducibility of the product, and meet its intended safety, efficacy, stability, and performance profile regardless of the manufacturing scale. N-(4-(2-(dimethylamino)ethyl)phenyl)-5-(3-methoxyphenyl)oxazol-2-amine manufacturers Symonds’ board has backed Walmsley’s leadership. In response to Elliott’s open attack earlier this month, the GSK board said it “strongly believes” Walmsley is the “right leader” for the company, citing “widespread and strong support” from GSK’s largest shareholders for Walmsley’s newly unveiled plan to improve the company’s performance. N-(endo-8-Azabicyclo[3.2.1]octa-3-yl)-1,5-dimethyl-2-phenylindole-3-carboxamide hydrochloride suppliers Competition is indeed “severe” from local firms, Wang said, but the company is working to add new drugs and indications to the market and is noticing increased volumes from national reimbursement deals. [NBu4][Ni(C6F5)2(S(O)P(C5H4FeC5H5)(OEt))] vendor & factory.